Clinical study results
Independent confirmation of efficacy for Freedom Anti-Inflammation Easy-to-Swallow Softgels®
Our anti-inflammatory claim is based on a 28-day placebo-controlled, randomized, double-blind study conducted at UCLA which showed a significant reduction of hs-CRP levels and a blunting of the increase in IL-6 level in adult subjects.
Ongoing research will study adult subjects for a period of 90 days to gauge Freedom Softgel effectiveness in controlling blood lipids and other parameters.
Proven in independent University-based study:
The effectiveness of Freedom Softgels® in controlling inflammation was proven in a recent IRB approved study, conducted by Dr. Matthew Budoff and his team at Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
The study followed 80 individuals (both male and female). Participants were randomly assigned to receive either Freedom Softgels® or a matching placebo, and researchers monitored key indicators in order to evaluate the effectiveness of Freedom Softgels® on reducing inflammation as well as its effect on blood pressure and endothelial reactivity.
In just 30 days, researchers found a significant reduction in high sensitivity C Reactive Protein and a blunting of the increase in Interleukin-6 – both key markers of inflammation. Also noted was a significant reduction in systolic blood pressure and a significant increase in the Omega-3 fatty acid index along with EPA levels and overall improved endothelial function.*
Results confirmed in peer-reviewed journal:
The results of the Freedom Anti-Inflammation Softgels® study conducted at the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center were recently accepted for publication in Clinical Nutrition – the internationally highly respected, peer-reviewed biomedical journal in the field of clinical nutrition. The acceptance by the Journal of the full length article, published as “A Combined Effect of Cavacurcumin, Eicosapentaenoic acid (Omega-3s), Astaxanthin and Gamma–linoleic acid (Omega-6) (CEAG) in Healthy Volunteers - A Randomized, Double-Blind, Placebo-Controlled Study,” confirms the clinical proof of the efficacy of the Freedom Softgels® formulation.
In addition, the study results have also been accepted for publication by the peer-reviewed Clinical Nutrition ESPEN, the online publication of the European Society for Clinical Nutrition and Metabolism.
* These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure or prevent any disease.
* These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure or prevent any disease.
